Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The DEPT. OF THE ARMY -- USAMRAA has issued a Tender notice for the procurement of a Dow Peer Reviewed Cancer, Clinical Trial Award in the USA. This Tender notice was published on 07 May 2026 and is scheduled to close on 05 Oct 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140802842, while the tender notice number is HT942526PRCRPCTA and Registering on the platform.
Procurement Summary
Country: USA
Summary: Dow Peer Reviewed Cancer, Clinical Trial Award
Deadline: 05 Oct 2026
Posting Date: 07 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140802842
Document Ref. No.: HT942526PRCRPCTA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33652000 - Antineoplastic and immunomodulating agentsPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details Summary: The Fiscal Year 2026 (Fy26) Peer Reviewed Cancer Research Program (Prcrp) Clinical Trial Award (Cta) Supports The Rapid Implementation Of Clinical Trials With The Potential To Have A Significant Impact On The Treatment Or Management Of Cancer Within At Least One Of The Fy26 Prcrp Topic Areas. Clinical Trials Proposed May Evaluate Promising New Products, Pharmacologic Agents (Drugs Or Biologics), Devices, Clinical Guidance, And/Or Emerging Approaches And Technologies. Proposed Projects May Range From Small Proof-Of-Concept Trials (E.G., Pilot, First-In-Human, Phase 0) That Evaluate The Effects Of Interventions Or Inform The Design Of More Advanced Trials To Large-Scale Trials (Up To Phase Iii) To Determine Efficacy In Relevant Patient Populations.Distinctive Features:• Applications To This Award Mechanism Must Include A Clinical Trial.• Projects Can Range From Phase 0 To Phase Iii.• If An Investigational New Drug (Ind) Application, Investigational Device Exemption (Ide), Or Equivalent, Is Required, A Regulatory Application Must Be Submitted To The Relevant Regulatory Agency By The Clinical Trial Award Application Submission Deadline. The Regulatory Application Should Be Specific To The Product And Indication To Be Tested In The Proposed Clinical Trial.• Applications Are Required To Include Patient Advocates.• Animal Studies Are Not Allowed Under This Award Mechanism. All Preclinical Work Must Be Completed Prior To The Award Start Date.Eligibilityeligible Applicantsmis... Documents
Posted Date: 2026-05-06 00:00:00
Funding instrument type: Grant
Similar Tenders
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google